Tweet
<img alt="" height="1" width="1" />
Drug That Helps Multiple Sclerosis Patients Walk May Also Aid Stroke Victims
Forbes
Ampyra, a pill approved to help patients with multiple sclerosis walk, has put Acorda Therapeutics in the small club of profitable biotechnology companies. The drug generated $266 million in annual sales last year, helping Acorda generate a net profit, ...
Acorda Drug Helps Stroke Patients Walk BetterTheStreet.com
Acorda Therapeutics Reports Positive AMPYRA Phase 2 Data For Post-Stroke ...RTT News
Acorda Therapeutics Announces Positive AMPYRA(R) (dalfampridine) Phase 2 ...MarketWatch (press release)
all 4 news articles »
More...